A detailed history of Pathstone Holdings, LLC transactions in Insulet Corp stock. As of the latest transaction made, Pathstone Holdings, LLC holds 5,848 shares of PODD stock, worth $1.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,848
Previous 6,132 4.63%
Holding current value
$1.5 Million
Previous $1.24 Million 10.02%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$180.69 - $239.01 $51,315 - $67,878
-284 Reduced 4.63%
5,848 $1.36 Million
Q2 2024

Aug 14, 2024

BUY
$161.02 - $206.98 $423,321 - $544,150
2,629 Added 75.05%
6,132 $1.24 Million
Q1 2024

May 13, 2024

BUY
$163.6 - $209.11 $176,688 - $225,838
1,080 Added 44.57%
3,503 $600,000
Q4 2023

Feb 14, 2024

BUY
$127.77 - $221.42 $309,586 - $536,500
2,423 New
2,423 $525,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $17.8B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.